Loomis, Sayles & Company’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,338
Closed -$429K – 906
2023
Q2
$429K Buy
+2,338
New +$337K ﹤0.01% 488
2018
Q4
– Sell
-812
Closed -$16K – 835
2018
Q3
$16K Buy
+812
New +$16.7K ﹤0.01% 766

Other funds holding ACLS

Loomis, Sayles & Company's ACLS Position: Q3 2023 in Review

Loomis, Sayles & Company sold out of Axcelis (ACLS) in Q3 2023, closing a stake of 2,338 shares — an estimated $429K sold.

Loomis, Sayles & Company first reported a position in ACLS in Q3 2018 and held it in 2 quarters. The position peaked at $429K in Q2 2023. 420 funds tracked by Wall St. Rank hold ACLS as of Q3 2023.

  • Loomis, Sayles & Company reported no remaining Axcelis position as of Q3 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 2,338 Axcelis shares in Q3 2023, an estimated $429K.
  • Loomis, Sayles & Company first reported a position in Axcelis in Q3 2018 and held it in 2 quarters.
  • Loomis, Sayles & Company's Axcelis position peaked at $429K in Q2 2023.
  • 420 funds tracked by Wall St. Rank held Axcelis as of Q3 2023.

Based on Loomis, Sayles & Company's 13F filing for Q3 2023, filed 9 Nov 2023.